Evidence map›Paper›PMID 23115189›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2012

Neuroprotective effects of reactive oxygen species mediated by BDNF-independent activation of TrkB.

Yang Zhong Huang, James O McNamara

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Nutrients · 2021
    Review
  11. Article
  12. Neuroprotective Potential of Verbascoside Isolated fromAntioxidants (Basel, Switzerland) · 2020
    Article
  13. Review
  14. Article
  15. A NeurotoxicFrontiers in molecular neuroscience · 2020
    Review
  16. TRPM7 senses oxidative stress to release ZnProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 3 countries.

Yang Zhong HuangDepartment of Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
James O McNamara
Duke University · USDuke University Hospital · US

Funding

Neurotrophins and EpileptogenesisR01NS056217 · NINDS · DUKE UNIVERSITY · PI MCNAMARA, JAMES O. · 2006 to 2023
$6.7M
Seizures Epileptogenesis and TrkB TransactivationR01NS065960 · NINDS · DUKE UNIVERSITY · PI MCNAMARA, JAMES O. · 2010 to 2014
$1.7M
NINDS NIH HHS NS065960NINDS NIH HHS R01 NS056217NINDS NIH HHS R01 NS065960
6 · The paper itself

Abstract

Reactive oxygen species (ROS) have diverse biological consequences in the mammalian CNS, but the molecular targets mediating these pleiotropic effects are incompletely understood. Like ROS, the neurotrophin receptor, TrkB receptor tyrosine kinase, has diverse effects in the developing and mature mammalian brain. Our discovery that zinc can transactivate TrkB, together with the finding that ROS can trigger zinc release from cytosolic zinc binding proteins, led us to hypothesize that ROS can transactivate TrkB in CNS neurons by a zinc-dependent mechanism. We found that both exogenous H(2)O(2) and endogenous ROS activate TrkB signaling by a Src family kinase-dependent but brain-derived neurotrophic factor-independent mechanism in cultured rat cortical neurons. Exogenous H(2)O(2) enhances cytosolic zinc content in a metallothionein-3 (MT-3)-requiring manner. Both exogenous H(2)O(2) and endogenous ROS mediated transactivation of TrkB requires intracellular zinc and MT-3. The ROS-triggered transactivation of TrkB exerts neuroprotective effects, because inhibition of TrkB kinase activity or uncoupling Shc signaling from TrkB exacerbates neuronal cell death induced by H(2)O(2). Thus, we propose a molecular signaling event whereby ROS induce release of zinc from cytosolic MT-3, the increased cytosolic zinc transactivates TrkB, and the enhanced Shc signaling downstream from TrkB promotes prosurvival effects. We suggest that such neuroprotective effects mediated by ROS are operative in diverse acute and chronic neurological disorders.

Indexed as

Neuroprotective AgentsAnimalsBlotting, WesternBrain-Derived Neurotrophic FactorCell DeathCells, CulturedCell SurvivalHEK293 CellsHippocampusHumansHydrogen PeroxideImmunoprecipitationIndicators and ReagentsMetallothionein 3MiceMice, Inbred C57BLBrain-Derived Neurotrophic FactorHydrogen PeroxideIndicators and ReagentsMetallothionein 3Mt3 protein, mouseNerve Tissue ProteinsNeuroprotective AgentsReactive Oxygen SpeciesReceptor, trkBsrc-Family KinasesZinc

Identifiers

PMID23115189
PMCPMC3535312
OpenAlexW1988783332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.